LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 28 July 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD |
|
|
||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
1,511,513 |
1.17% |
465,371 |
0.36% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
355,000 |
0.28% |
383,659 |
0.30% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
1,866,513 |
1.45% |
849,030 |
0.66% |
||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities |
Price per unit |
Purchase | 100 |
211.0400 USD |
Purchase | 100 |
210.9100 USD |
Purchase | 103 |
211.3100 USD |
Purchase | 130 |
212.6500 USD |
Purchase | 146 |
209.9300 USD |
Purchase | 200 |
210.8150 USD |
Purchase | 326 |
210.5074 USD |
Purchase | 400 |
210.4250 USD |
Purchase | 1,000 |
210.3260 USD |
Purchase | 1,610 |
209.9400 USD |
Purchase | 2,300 |
210.3911 USD |
Purchase | 2,400 |
210.4182 USD |
Purchase | 2,623 |
209.9402 USD |
Purchase | 2,717 |
210.1592 USD |
Purchase | 7,664 |
210.6286 USD |
Purchase | 12,368 |
210.4405 USD |
Sale | 19 |
210.6136 USD |
Sale | 32 |
211.0100 USD |
Sale | 99 |
209.7600 USD |
Sale | 100 |
209.9100 USD |
Sale | 100 |
210.9500 USD |
Sale | 100 |
210.3800 USD |
Sale | 103 |
211.3100 USD |
Sale | 130 |
212.6500 USD |
Sale | 146 |
209.9300 USD |
Sale | 200 |
210.2075 USD |
Sale | 400 |
210.8050 USD |
Sale | 500 |
210.6940 USD |
Sale | 1,155 |
209.9400 USD |
Sale | 1,500 |
210.2753 USD |
Sale | 2,200 |
210.4373 USD |
Sale | 2,300 |
210.4403 USD |
Sale | 2,823 |
210.0021 USD |
Sale | 8,150 |
210.5366 USD |
Sale | 13,694 |
210.4275 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 29 Jul 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |